Harmony Biosciences to Present at 2026 Cantor Global Healthcare Conference

Harmony Biosciences has announced its participation in the 2026 Cantor Global Healthcare Conference, where executives will discuss clinical progress and strategic initiatives. The presentation aims to engage institutional investors and highlight the company’s therapeutic pipeline.